Checkpoint blockade with pembrolizumab induce graft-versus-host disease for patients with refractory acute leukemia heavily treated after allogeneic transplantation

Tsai, ChengHongChengHongTsai2020-09-292020-09-292017-030268-3369https://scholars.lib.ntu.edu.tw/handle/123456789/515718Checkpoint blockade with pembrolizumab induce graft-versus-host disease for patients with refractory acute leukemia heavily treated after allogeneic transplantation5686556956865569